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Conclusions: The overall prevalence of coronary artery disease in a
study group of patients with rheumatic heart disease undergoing
valve surgery in western India in single centre is 12.2%. This
prevalence is much lower than the ﬁgures reported earlier in
the Western literature.
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Background: Degenerative aortic stenosis (DAS) and coronary
artery disease (CAD) share common risk factors. In some of the
previous studies statins have been used to retard the progression
of aortic stenosis, but the results are inconsistent
Objective (aim): To study the risk factor proﬁle in degenerative
aortic stenosis with and without associated CAD.
Methods: One hundred and ten patients of DAS above the age of
40 years have undergone clinical, biochemical and echocardio-
graphic evaluation. Coronary angiograms were done in 68% of
the cases.
Results: Male to female ratio is 2:1. Patients of DAS with CAD
showed higher prevalence of diabetes, hypertension, dyslipide-
mia, smoking and family history of CAD. Prevalence of obesity and
bicuspid aortic valve by echocardiogramwas high in those without
CAD.
Conclusion: Our observations are in agreement with those of Kora/
Monica and SEAS studies but the prevalence of diabetes is high in
our study. This is the ﬁrst Indian study to study the risk factor
proﬁles in cases of DAS.
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Severe MS is usually symptomatic and is treated by BMV or sur-
gery, whereas mild to moderate mitral stenosis is usually asymp-
tomatic or mildly symptomatic and managed medically. Patients
in the latter group may become symptomatic during episodes of
exercise and increased heart rate. As increase in heart rate occurs
mostly at the expense of diastole, there is shortening of the
diastolic ﬁlling period, and in the presence of obstruction at the
mitral valve this results in increased left atrial pressure. Subse-
quently, pulmonary capillary wedge pressure rises, resulting in
effort intolerance and dyspnea. Theoretically, negative chronotro-
pic agents such as blockers and CCBs should be helpful in con-
trolling tachycardia-related symptoms by improving diastolic
ﬁlling and preventing rise in pulmonary capillary wedge pressure.
However, associated negative inotropic effect on myocardium and
effect on neuromuscular system may negate the beneﬁcial effects
of these drugs. CCBs have little role in controlling heart rate when
the patient is in sinus rhythm. Results from various clinical and
hemodynamic studies with these agents have been conﬂicting.
We studied 97 patients of mitral stenosis in sinus rhythm pre-
sented with exertional symptoms. The effectiveness of metoprolol
is compared with ivabradin in alleviating these exertional symp-
toms in a randomized, open label non cross over study. We also
assessed various stress ECG parameters, 24 hr Holter parameters
and 2D echo parameters to objectively compare the effect of
ivabradin and metoprolol in these patients. The ﬁndings are as
follows:
 Ivabradin and metoprolol both are effective in controlling
exertional symptoms.
 Signiﬁcant improvement in objective parameters like TMT
(work capacity, baseline heart rate and maximum heart
rate), 24 hr Holter (minimum heart rate, average heart rate
and maximum heart rate) and 2D echocardiography (right
ventricular systolic pressure) are seen with both drugs.
 Ivabradin control the exertional symptoms signiﬁcantly
more than metoprolol.
 Objective parameters improve signiﬁcantly more with ivab-
radin than metoprolol except average heart rate reduction.
Conclusion: Ivabradin is better than metoprolol in medical man-
agement of mitral stenosis patients Ivabradin should be strongly
Table 2 – Distribution of valve lesions and coronary artery
disease.
Valve involved Total no.
of patients
(%) of patients
with CAD
Mitral valve 7 13.5
Aortic valve 62 15.3
Combined 7 9.0
Total 188 12.2
Table 3 – Reported prevalence of coronary artery disease
in mitral valve disease.
Author Year No. of patients
Reported
Studied
prevalence (%)
Befeler et al. 1970 26 50
Lacy et al. 1977 67 32
Baxter et al. 1978 82 22
Saltups 1982 100 23
Chun et al 1982 82 26
Czer et al. 1984 56 27
Mattina et al. 1986 96 28
CMC Vellore 2003 96 13.5
Table 4 – Reported prevalence of coronary artery disease
in aortic valve disease.
Author Year No. of patients
reported
Studied
prevalence (%)
Coleman & Soloff 1970 77 17.7
Harris et al. 1975 69 23.2
Baxter et al. 1978 47 17
Vandeplas et al. 1988 192 24
Ravi Kishore et al. 1988 106 5.6
CMC Vellore 2003 124 15.3
Saltups 1982 100 30
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